BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Liver
,
Laryngoscope
,
Fenofibrate
,
rs6983267
,
FXYD4
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
myc oncogenes
Summary
General Info
Curated Studies
Most Correlated Studies
Induced pluripotent stem cells by direct delivery of Oct4, Sox2, Klf4,and c-Myc proteins
DLBCL cells with different oncogenic mutations
Mammary tumors from 8 different mouse models of human breast cancer
Mammary tumors from multiple genetic mouse breast cancer models
Transgenic mutation in oncogenes and tumor suppressor genes in mammary tissue
Explore Curated Studies Results
Literature
Most Relevant Literature
Radiosensitizing Effect of Celastrol by Inhibiting G2/M Phase Arrest Induced by the c-myc Gene of Hu…
Plasmablastic lymphomas show restricted EBV latency profile and MYC gene aberrations.
HIV-associated DLBCL: Clinicopathological factors including dual-colour chromogenic in situ hybridis…
The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-…
Survey of activation-induced genome architecture reveals a novel enhancer of Myc.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase 1/2 Study to Evaluate OTX-2002 in Patients With Hepatocellular Carcinoma and Other Solid Tum…
A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcript…
Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma
Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma
Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myelo…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ